Glioblastoma multiforme

EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2

EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2

Glioblastoma multiforme (GBM) is the most malignant primary human brain cancer and cannot be cured by any therapy available today. Current therapy includes complex treatments of neurosurgical resection, radiotherapy, and […]